Anticipated Zika Vaccine Delay: Speed Not as Swift as Expected
In a significant development, a pharmaceutical company named Valneva is set to commence human trials for its experimental Zika vaccine. The announcement, made earlier this week, has been met with a positive response, although the World Health Organization (WHO) has emphasized that there is no need to panic about the vaccine.
The initial trial will involve 40 healthy individuals, and the vaccine will be tested on those with Zika virus infection following the initial phase. After the initial trial, the vaccine will be tested on a larger number of people. However, the WHO has not provided a specific timeline for when the vaccine may be ready for public use, suggesting it could take several years.
The details about the Zika vaccine testing, such as the location and specific trial design, have not been disclosed at this time. It's important to note that the vaccine is still in the testing phase and is not yet ready for use.
While the development of a Zika vaccine is promising, the WHO continues to recommend using bug spray as a preventative measure against Zika. This recommendation stands, as the vaccine is still in the testing phase and not yet available for public use.
The first report about this development was published by CNN, highlighting the importance of this breakthrough in the fight against the Zika virus. As the trials progress, more information is expected to be released, providing further insight into the potential of this experimental Zika vaccine.
Read also:
- Recognition of Exceptional Patient Care: Top Staff Honored by Medical Center Board
- A continuous command instructing an entity to halts all actions, repeated numerous times.
- Oxidative Stress in Sperm Abnormalities: Impact of Reactive Oxygen Species (ROS) on Sperm Harm
- Is it possible to receive the hepatitis B vaccine more than once?
